News Release

MINNEAPOLIS, March 3, 1999 -- Chronimed Inc. (Nasdaq: CHMD), announced today that Gregory H. Keane has been promoted to vice president, finance from corporate controller. Prior to joining Chronimed three years ago, Keane was employed by National Computer Systems where he served as controller, and as director, financial planning and operations. He has more than 20 years of financial experience and holds designations as a CPA and CMA. Maury Taylor, Chronimed's chairman and chief executive officer, said “we are pleased that we are able to promote from within, and this recognizes Greg's contributions to the company, particularly in the area of financial controls and operations”.

Keane will assume many responsibilities formerly held by Norman A. Cocke, senior vice president and chief financial officer, who has resigned his position, effective March 15, 1999. “We are sorry to see Norm leave,” said Taylor. “Norm has expressed an interest in running a company in a chief executive or general management capacity at this stage in his career. We appreciate Norm's many contributions and his counsel as the company has grown."” Cocke will serve as a consultant to the company during the balance of 1999.

Chronimed Inc. is a leading integrated healthcare company specializing in diagnostic products, specialty pharmacy services, and disease management for people with chronic health conditions. The Company develops, manufactures, markets, and distributes pharmaceuticals, medical diagnostic products, and provides specialized patient management services nationwide for people with long-term chronic conditions such as HIV/AIDS, diabetes, organ transplants, and diseases treated with injectable medications. Chronimed works directly with patients, providers, and payors to improve clinical and cost-of-care outcomes. Chronimed's web site address is www.chronimed.com.

As a cautionary note to investors, certain matters discussed in this press release are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such matters involve risks and uncertainties that may cause actual results to differ materially, including the following: changes in economic conditions; general competitive factors; pressures on product margins; the Company's ability to execute its sales and marketing plans; changes in the status of managed care contracts; and the risks described from time to time in the Company's public reports filed with the SEC.

March 13, 2000

Contacts:
Paul S. Dunn
Investor Relations
or
Maurice R. Taylor, II
Chairman and CEO

Chronimed Inc.
(612) 979-3600